2NAF

Solution structure of peptidyl-tRNA hydrolase from Mycobacterium smegmatis

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
2	3D HNCO	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
3	3D HNCA	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
4	3D CBCA(CO)NH	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
5	3D HNCACB	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
6	3D H(CCO)NH	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
7	3D C(CO)NH	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
8	3D HCCH-TOCSY	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	100% D2O	50	6.5	ambient	298
9	3D 1H-15N NOESY	1 mM [U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	95% H2O/5% D2O	50	6.5	ambient	298
10	3D 1H-13C NOESY aliphatic	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	100% D2O	50	6.5	ambient	298
11	3D 1H-13C NOESY aromatic	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	100% D2O	50	6.5	ambient	298
12	2D 1H-13C HSQC aliphatic	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	100% D2O	50	6.5	ambient	298
13	2D 1H-13C HSQC aromatic	1 mM [U-100% 13C; U-100% 15N] Protein, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide, 1 mM AEBSF protease inhibitor, 1 mM DTT	100% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Bruker	AVANCE	700
3	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	500
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	chemical shift assignment	CARA		Keller and Wuthrich